Open AccessDrug checking to detect fentanyl and new psychoactive substances
Author(s) -
Joseph J. Palamar,
Alberto Salomone,
Monica J. Barratt
Publication year - 2020
Publication title -
current opinion in psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.66
H-Index - 90
eISSN - 1473-6578
pISSN - 0951-7367
DOI - 10.1097/yco.0000000000000607
Subject(s) - drug , fentanyl , medicine , population , pharmacology , environmental health
Drug checking services invite drug consumers to anonymously submit drug samples for chemical analysis and provide feedback of results. Drugs are tested for strength/dose and/or presence of adulterants. Drug checking appears to be more common in recent years in response to increases in fentanyl-related deaths and the proliferation of new psychoactive substances (NPS). We aim to provide information regarding the current state of drug checking in relation to analysis methods, adulteration rates, and behavioral responses to results.